eBay
EBAY
Halozyme Therapeutics
HALO
Constellation Brands
STZ
4
Workday
WDAY
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -87.22%63.78K | 0 | -93.86%5.43K | 0 | -48.40%58.35K | -83.32%498.92K | -74.07%157.89K | -76.31%88.4K | -85.78%139.54K | -88.99%113.08K |
Operating revenue | -87.22%63.78K | --0 | -93.86%5.43K | --0 | -48.40%58.35K | -83.32%498.92K | -74.07%157.89K | -76.31%88.4K | -85.78%139.54K | -88.99%113.08K |
Cost of revenue | 29.55%6.65M | -5.60%4.11M | 23.37%286.03K | 223.74%1.07M | 438.33%1.18M | -15.05%5.13M | 301.38%4.35M | -75.72%231.84K | -88.26%332.03K | -81.33%219.79K |
Gross profit | -42.12%-6.59M | 2.04%-4.11M | -95.62%-280.6K | -458.44%-1.07M | -954.14%-1.12M | -51.82%-4.64M | -782.73%-4.19M | 75.35%-143.44K | 89.57%-192.48K | 29.00%-106.71K |
Operating expense | -52.68%11.13M | -55.68%2.51M | -73.01%1.65M | -52.50%2.88M | -28.12%4.09M | 16.30%23.52M | -12.40%5.66M | 16.74%6.1M | 47.22%6.07M | 28.91%5.69M |
Selling and administrative expenses | -40.16%9.64M | -41.32%2.41M | -65.75%1.63M | -38.33%2.26M | -6.48%3.33M | 20.37%16.1M | 22.20%4.11M | 40.66%4.76M | 19.15%3.67M | 0.53%3.56M |
-Selling and marketing expense | -42.45%990.47K | 15.10%220.48K | -44.56%216.61K | -32.27%285.04K | -62.63%268.36K | -8.19%1.72M | -37.78%191.55K | 1.54%390.68K | 24.80%420.86K | -15.00%718.09K |
-General and administrative expense | -39.88%8.65M | -44.07%2.19M | -67.65%1.41M | -39.12%1.98M | 7.70%3.06M | 25.02%14.38M | 28.24%3.92M | 45.68%4.37M | 18.46%3.25M | 5.40%2.84M |
Research and development costs | -79.87%1.49M | -93.83%95.44K | -98.89%14.78K | -74.12%622.57K | -64.30%760.42K | 8.36%7.42M | -50.01%1.55M | -27.34%1.34M | 129.79%2.41M | 144.09%2.13M |
Operating profit | 37.08%-17.72M | 32.85%-6.62M | 69.13%-1.93M | 36.81%-3.96M | 10.04%-5.22M | -20.96%-28.16M | -42.05%-9.85M | -7.51%-6.24M | -4.94%-6.27M | -27.00%-5.8M |
Net non-operating interest income expense | 9.71%484.33K | 42.70%101.4K | 150.47%89.06K | 19.86%140.57K | 6.19%153.3K | 142.18%441.44K | -35.92%71.06K | -31.35%35.56K | 117.28K | 1,523.66%144.36K |
Non-operating interest income | 9.71%484.33K | 42.70%101.4K | 150.47%89.06K | 19.86%140.57K | 6.19%153.3K | 142.18%441.44K | -35.92%71.06K | -31.35%35.56K | --117.28K | 1,523.66%144.36K |
Other net income (expense) | 340.13%15.48M | 399.63%932.05K | 137.39%2.39M | 7,253.91%10.73M | 700.04%1.42M | -4,146.70%-6.45M | -350.88%-311.07K | -9,110.30%-6.39M | 5,363.69%145.96K | 905.29%177.98K |
Gain on sale of security | 393.55%18.92M | 1,291.95%3.71M | 144.74%2.86M | 6,947.35%10.93M | 1,124.55%1.42M | -4,146.70%-6.45M | -350.88%-311.07K | -9,110.30%-6.39M | 1,250.89%155.13K | 626.13%116.28K |
Special income (charges) | ---3.4M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Less:Impairment of capital assets | --1.66M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Less:Other special charges | --1.1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Write off | --647.83K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | ---39.29K | --628.19K | ---468.98K | -2,065.72%-198.51K | ---- | ---- | ---- | ---- | -185.62%-9.17K | --61.7K |
Income before tax | 94.86%-1.76M | 44.69%-5.58M | 104.37%550.56K | 215.18%6.91M | 33.55%-3.64M | -48.94%-34.16M | -50.61%-10.09M | -121.59%-12.59M | -0.48%-6M | -19.59%-5.48M |
Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Net income | 94.86%-1.76M | 44.69%-5.58M | 104.37%550.56K | 215.18%6.91M | 33.55%-3.64M | -48.94%-34.16M | -50.61%-10.09M | -121.59%-12.59M | -0.48%-6M | -19.59%-5.48M |
Net income continuous Operations | 94.86%-1.76M | 44.69%-5.58M | 104.37%550.56K | 215.18%6.91M | 33.55%-3.64M | -48.94%-34.16M | -50.61%-10.09M | -121.59%-12.59M | -0.48%-6M | -19.59%-5.48M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 94.86%-1.76M | 44.69%-5.58M | 104.37%550.56K | 215.18%6.91M | 33.55%-3.64M | -48.94%-34.16M | -50.61%-10.09M | -121.59%-12.59M | -0.48%-6M | -19.59%-5.48M |
Preferred stock dividends | 128.31%10.68M | -28.43%2.34M | 59.48%2.25M | 2.55M | 3.55M | 4.68M | 3.27M | 1.41M | ||
Other preferred stock dividends | 0 | 0 | 0 | 199K | 0 | 199K | ||||
Net income attributable to common stockholders | 68.14%-12.44M | 40.71%-7.92M | 88.04%-1.7M | 172.77%4.37M | -31.24%-7.19M | -70.21%-39.04M | -99.39%-13.36M | -149.90%-14.2M | -0.48%-6M | -19.59%-5.48M |
Basic earnings per share | 75.34%-2.02 | 54.41%-1.24 | 91.64%-0.25 | 160.94%0.78 | -24.79%-1.46 | -65.45%-8.19 | -88.89%-2.72 | -143.09%-2.99 | 0.00%-1.28 | -21.88%-1.17 |
Diluted earnings per share | 75.34%-2.02 | 54.41%-1.24 | 91.64%-0.25 | 110.94%0.14 | -24.79%-1.46 | -65.45%-8.19 | -88.89%-2.72 | -143.09%-2.99 | 0.00%-1.28 | -21.88%-1.17 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |